Severe/Very Severe COVID-19 Illness

1

Review clinical trials related to Severe/Very Severe COVID-19 Illness. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease

Location

Anywhere

By Last updated

Status: Available

Managed Access Programs for INC424, Ruxolitinib

The purpose of this registration is to list Managed Access Programs (MAPs) related to INC424, Ruxolitinib

Trial details

Age: 2+Biological sex: AllType: Expanded AccessSponsor: Novartis PharmaceuticalsUpdated: Nov 18, 2025

Eligibility criteria

An independent request was received from a licensed physician. [+6]